R Harf

454 total citations
23 papers, 381 citations indexed

About

R Harf is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, R Harf has authored 23 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology and Allergy. Recurrent topics in R Harf's work include Allergic Rhinitis and Sensitization (6 papers), Pneumonia and Respiratory Infections (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). R Harf is often cited by papers focused on Allergic Rhinitis and Sensitization (6 papers), Pneumonia and Respiratory Infections (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). R Harf collaborates with scholars based in France, Austria and United States. R Harf's co-authors include M Perrin‐Fayolle, Rudolf Valenta, P Deviller, M. Leclercq, G. Panteix, Y. Pachéco, J C Guérin, B Montagnon, Yveline Frobert and M. Guillaumont and has published in prestigious journals such as Annals of the New York Academy of Sciences, Thorax and Journal of Antimicrobial Chemotherapy.

In The Last Decade

R Harf

22 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Harf France 9 100 89 86 84 78 23 381
William N. Sokol United States 13 125 1.3× 86 1.0× 54 0.6× 87 1.0× 44 0.6× 18 535
Christy Varughese United States 9 41 0.4× 48 0.5× 69 0.8× 105 1.3× 257 3.3× 22 384
J. Cuesta Spain 11 50 0.5× 17 0.2× 223 2.6× 271 3.2× 255 3.3× 28 544
Anna Vila Spain 8 27 0.3× 26 0.3× 112 1.3× 177 2.1× 11 0.1× 25 363
Robert Skinner United States 9 11 0.1× 103 1.2× 35 0.4× 37 0.4× 129 1.7× 13 398
Mabrouk Ghonaim Egypt 12 22 0.2× 74 0.8× 14 0.2× 13 0.2× 32 0.4× 34 378
Harry S. Porterfield United States 7 47 0.5× 11 0.1× 88 1.0× 275 3.3× 16 0.2× 20 378
Oki Suwarsa Indonesia 10 10 0.1× 80 0.9× 103 1.2× 37 0.4× 24 0.3× 75 440
Wu–Chang Yang Taiwan 11 57 0.6× 58 0.7× 10 0.1× 25 0.3× 23 0.3× 26 461
Paul Stevenson United Kingdom 10 19 0.2× 52 0.6× 42 0.5× 21 0.3× 38 0.5× 10 392

Countries citing papers authored by R Harf

Since Specialization
Citations

This map shows the geographic impact of R Harf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Harf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Harf more than expected).

Fields of papers citing papers by R Harf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Harf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Harf. The network helps show where R Harf may publish in the future.

Co-authorship network of co-authors of R Harf

This figure shows the co-authorship network connecting the top 25 collaborators of R Harf. A scholar is included among the top collaborators of R Harf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Harf. R Harf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harf, R. (2013). Pollinoses : traitements médicamenteux. Revue des Maladies Respiratoires. 30(6). 458–462. 1 indexed citations
2.
Freymond, N., et al.. (2005). Un cas d’aspergillome associé à une bronchite aspergillaire traités par voriconazole. Revue des Maladies Respiratoires. 22(5). 811–814. 7 indexed citations
3.
Harf, R & C. Déchamp. (2001). Pollinosis and anti-allergic drug use: ambroisiosis in the Rhône-Alpes region.. Revue des Maladies Respiratoires. 18(5). 517–522. 2 indexed citations
4.
Harf, R & C. Déchamp. (2001). [Pollinosis and use of anti-allergic drugs: ragweed in the Rhone-Alpine region].. PubMed. 18(5). 517–22. 5 indexed citations
5.
Harf, R, et al.. (1995). Identification of profilin as an IgE‐binding component in latex from Hevea brasiliensis: clinical implications. Clinical & Experimental Allergy. 25(4). 332–339. 104 indexed citations
6.
Liard, R, R Harf, M Korobaeff, V Schwoebel, & Françoise Neukirch. (1994). HIV infection and tuberculosis: an epidemiological study from a French register. Tubercle and Lung Disease. 75(4). 291–296. 4 indexed citations
7.
Panteix, G., et al.. (1994). Accumulation of pefloxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage. Journal of Antimicrobial Chemotherapy. 33(5). 979–985. 16 indexed citations
8.
Panteix, G., et al.. (1993). In-vitro concentration of azithromycin in human phagocytic cells. Journal of Antimicrobial Chemotherapy. 31(suppl E). 1–4. 46 indexed citations
9.
Harf, R, et al.. (1993). [Unrecognized occupational risk of pleural mesothelioma. The example of the Rhône-Alps region].. PubMed. 10(5). 453–8. 2 indexed citations
10.
Harf, R, et al.. (1992). [Biological and clinical prevalence of pollinosis caused by ragweeds of the upper valley of the Rhône corridor].. PubMed. 24(3). 95–7. 5 indexed citations
11.
Pachéco, Y., C Charrin, G. Cozon, et al.. (1989). [Karyotype study of blood lymphocytes in sarcoidosis].. PubMed. 45(5). 199–202. 1 indexed citations
12.
Panteix, G., et al.. (1988). Josamycin pulmonary penetration determined by broncho-alveolar lavage in man. Journal of Antimicrobial Chemotherapy. 22(6). 917–921. 17 indexed citations
13.
APRIN, HORMOZAN & R Harf. (1988). Stabilization of Atlantoaxial Instability. Orthopedics. 11(12). 1687–1693. 7 indexed citations
14.
Harf, R, et al.. (1988). Spiramycin uptake by alveolar macrophages. Journal of Antimicrobial Chemotherapy. 22(Supplement_B). 135–140. 19 indexed citations
15.
Harf, R, et al.. (1986). Reduced Prevalence of Smokers in Sarcoidosis. Annals of the New York Academy of Sciences. 465(1). 625–631. 56 indexed citations
16.
Perrin‐Fayolle, M, et al.. (1985). [Pulmonary sarcoidosis. Study of the distribution of active alveolitis assessed by comparison of data from radiological examination, gallium 67 scintigraphy and double bronchoalveolar lavage].. PubMed. 41(1). 31–7. 2 indexed citations
17.
Guillaumont, M., et al.. (1982). Determination of rifampicin, desacetylrifampicin, isoniazid and acetylisoniazid by high-performance liquid chromatography: Application to human serum extracts, polymorphonucleocytes and alveolar macrophages. Journal of Chromatography B Biomedical Sciences and Applications. 232(2). 369–376. 28 indexed citations
18.
Perrin‐Fayolle, M, et al.. (1981). Angiotensin converting enzyme in bronchoalveolar lavage fluid in pulmonary sarcoidosis.. Thorax. 36(10). 790–792. 20 indexed citations
19.
Perrin‐Fayolle, M, Arjan Bel, R Harf, et al.. (1980). [Asthma and gastro-esophageal reflux. Results of a survey over 150 cases (author's transl)].. PubMed. 36(4). 225–30. 25 indexed citations
20.
Perrin‐Fayolle, M, G Braillon, R Lombard-Platet, et al.. (1980). [Asthma and gastro-esophagal reflux (GER). Results of surgical treatment of reflux in 50 patients (author's transl)].. PubMed. 36(4). 231–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026